Market revenue in 2021 | USD 178.4 million |
Market revenue in 2030 | USD 284.8 million |
Growth rate | 5.3% (CAGR from 2021 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats, Other Animal Type |
Key market players worldwide | Zoetis, Virbac SA, Elanco Animal Health Inc, Boehringer Ingelheim, CEVA Inc, Dechra Pharmaceuticals, Vetoquinol SA, NextGen Healthcare, K-Laser, Norbrook |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal arthritis market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 60.31% in 2021. Horizon Databook has segmented the UK companion animal arthritis market based on dogs, cats, other animal type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK companion animal arthritis market , including forecasts for subscribers. This country databook contains high-level insights into UK companion animal arthritis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account